| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |